超声造影对良恶性软组织肿块鉴别诊断价值的Meta分析
该Meta分析检索截至2020年3月24日的文献,纳入5项研究共746例患者,评估超声造影鉴别良恶性软组织肿块的效能:合并敏感度76%(95%CI 71%-81%)、特异度67%(95%CI 62%-71%)、诊断比值比7.37(95%CI 3.78%-14.35)、AUC 0.77。作者认为超声造影是鉴别良恶性软组织肿块的有效方法。
要点
- 超声造影鉴别良恶性软组织肿块的合并敏感度76%、特异度67%,AUC 0.77。
- 合并诊断比值比7.37(95%CI 3.78%-14.35),异质性I²=66.6%。
- 不同超声造影指标试验的诊断效能存在差异。
核心结论
- 作者认为超声造影是鉴别良恶性软组织肿块的有效方法。
- 合并敏感度76%(95%CI 71%-81%;I²=74.5%),合并特异度67%(95%CI 62%-71%;I²=36.5%)。
- 合并诊断比值比7.37(95%CI 3.78%-14.35;I²=66.6%),总体AUC 0.77(标准误0.0392)。
- 亚组分析显示不同超声造影指标试验的诊断效能不同。
研究设计与样本
- 研究类型为Meta分析,检索PubMed、Ovid、Cochrane和Web of Science中2020年3月24日前发表的文献。
- 按纳入标准最终纳入5项研究,共746例患者。
诊断标准与关键数值
- 超声造影鉴别良恶性软组织肿块的合并敏感度76%(95%CI 71%-81%),合并特异度67%(95%CI 62%-71%)。
- 合并诊断比值比7.37(95%CI 3.78%-14.35),总体AUC 0.77(标准误0.0392)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 敏感度合并分析异质性I²=74.5%。
- 诊断比值比合并分析异质性I²=66.6%。
- 亚组分析显示不同超声造影指标试验的诊断效能不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This meta-analysis was aimed at investigating the value of using contrast-enhanced ultrasound (CEUS) in the differential diagnosis of benign and malignant soft tissue masses (STMs). Relevant studies published before March 24, 2020 were identified through a comprehensive search of PubMed, Ovid, Cochrane and Web of Science. According to the inclusion criteria, five studies were selected comprising 746 patients. In the differential diagnosis of benign and malignant STMs, the pooled sensitivity and specificity of CEUS were 76% (95% confidence interval [CI]: 71%-81%; heterogeneity [I2] = 74.5%) and 67% (95% CI: 62%-71%; I2 = 36.5%), respectively. The diagnostic odds ratio was 7.37 (95% CI: 3.78%-14.35; I2 = 66.6%). The overall area under the curve was 0.77 (standard error: 0.0392). Subgroup analysis revealed that different index tests of CEUS resulted in different diagnostic performance. Importantly, CEUS is an effective method for the differential diagnosis between benign and malignant STMs.
引用
- Wang P, Wu M, Li A, et al. Diagnostic Value of Contrast-Enhanced Ultrasound for Differential Diagnosis of Malignant and Benign Soft Tissue Masses: A Meta-Analysis. Ultrasound Med Biol. 2020. PMID: 32907771. doi:10.1016/j.ultrasmedbio.2020.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。